• English
  • Deutsch
  • Log In
    Password Login
    Research Outputs
    Fundings & Projects
    Researchers
    Institutes
    Statistics
Repository logo
Fraunhofer-Gesellschaft
  1. Home
  2. Fraunhofer-Gesellschaft
  3. Scopus
  4. Encapsulating In Vitro Transcribed circRNA into Lipid Nanoparticles Via Microfluidic Mixing
 
  • Details
  • Full
Options
2024
Book Article
Title

Encapsulating In Vitro Transcribed circRNA into Lipid Nanoparticles Via Microfluidic Mixing

Abstract
This chapter serves as a guide for researchers embarking on circular RNA-based translational studies. It provides a foundation for the successful encapsulation of circular RNA into lipid nanoparticles (LNPs) and facilitates progress in this emerging field. Crucial scientific methods and techniques involved in the formulation process, particle characterization, and downstream processing of circ-LNPs are covered. The production of in vitro transcribed circular RNA-containing LNPs based on a commercially available lipid mix is provided, in addition to the fundamentals for successful encapsulation based on lipid mixes composed of single components. Furthermore, the transfection and validation protocols for the identification of a functional and potentially therapeutic circRNA candidate for initial in vitro verification, before subsequent LNP studies, are explained.
Author(s)
Juchem, Malte
Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM  
Cushman, Sarah
Hannover Medical School
Lu, Dongchao
Hannover Medical School
Chatterjee, Shambhabi
Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM  
Bär, Christian  
Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM  
Thum, Thomas
Hannover Medical School
Journal
Methods in Molecular Biology  
Funder
European Research Council
DOI
10.1007/978-1-0716-3678-7_14
Language
English
Fraunhofer-Institut für Toxikologie und Experimentelle Medizin ITEM  
Keyword(s)
  • Cardiomyocytes

  • Circular RNA

  • In vitro transcription (IVT)

  • Lipid nanoparticle (LNP)

  • RNA therapeutics

  • Cookie settings
  • Imprint
  • Privacy policy
  • Api
  • Contact
© 2024